Long-term remission of lymphocytic hypereosinophilic syndrome with imatinib mesylate.

Christoforidou, Anna; Kotsianidis, Ioannis; Margaritis, Dimitrios; Anastasiadis, Athanasios; Douvali, Eudoxia; Tsatalas, Costas

Christoforidou, Anna; Kotsianidis, Ioannis; Margaritis, Dimitrios; Anastasiadis, Athanasios; Douvali, Eudoxia; Tsatalas, Costas.

Am J Hematol ; 87(1): 131-2, 2012 Jan.

Article in En | MEDLINE | ID: mdl-21919038

Subject(s)

Hypereosinophilic Syndrome/drug therapy; Piperazines/therapeutic use; Protein Kinase Inhibitors/therapeutic use; Pyrimidines/therapeutic use; Aged; Benzamides; Bone Marrow Cells/metabolism; Bone Marrow Cells/pathology; Female; Humans; Hypereosinophilic Syndrome/metabolism; Imatinib Mesylate; Lymphocytes/metabolism; Receptors, Antigen, T-Cell, alpha-beta/metabolism; Remission Induction; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Hypereosinophilic Syndrome / Protein Kinase Inhibitors Limits: Aged / Female / Humans Language: En Journal: Am J Hematol Year: 2012 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google